Allosteric MAPKAPK2 inhibitors improve plaque stability in advanced atherosclerosis.
Autor: | Ozcan, Lale1 (AUTHOR) lo2192@cumc.columbia.edu, Kasikara, Canan1 (AUTHOR), Yurdagul, Arif1 (AUTHOR), Kuriakose, George1 (AUTHOR), Hubbard, Brian2 (AUTHOR), Serrano-Wu, Michael H.2 (AUTHOR), Tabas, Ira1,3,4 (AUTHOR) |
---|---|
Zdroj: | PLoS ONE. 5/13/2021, Vol. 16 Issue 5, p1-13. 13p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |